Introduction
Pluripotent stem cells (PSCs) are able to differentiate, in in vitro cultures, into cells from all three germ layers and, in vivo, to grow teratomas and complement blastocyst development. PSCs are derived from early embryos (i) as embryonic stem cells (ESCs) or epiblast stem cells or (ii) from migrating primordial germ cells (PGCs) as embryonic germ cells. [1] [2] [3] In addition, a novel type of PSCs, known as inducible PSCs (iPSCs), was recently obtained after transduction of somatic cells with genes encoding embryonic transcription factors. 4, 5 Some investigators postulated the presence of Oct4 þ PSCs in postnatal adult tissues that are able to differentiate in vitro into cells from all three germ layers; 6, 7 however, their in vivo pluripotentiality was not shown. Nevertheless, some recent reports cast some doubts on whether Oct4 is truly expressed in cells isolated from adult tissues. 8, 9 Recently, our group identified a population of very small embryonic-like stem cells (VSELs) in adult murine tissues including bone marrow (BM) 10 and human cord blood. 11 These cells, isolated from BM by multiparameter fluorescence-activated cell sorter (FACS) as a population of Sca-1 þ lin À CD45 À , are: (i) very small in size (B3-6 mm); ii) express pluripotent markers such as Oct4, Nanog, Rex-1 and SSEA-1; and iii) possess large nuclei containing unorganized chromatin (euchromatin). We have shown that VSELs are mobilized into peripheral blood during organ injuries (for example, heart infarct, stroke), [12] [13] [14] which suggests that they may contribute in regeneration of the damaged tissues.
Unlike ESCs, highly purified BM-derived Oct4 þ VSELs do not proliferate in vitro if cultured alone and do not grow teratomas in vivo. However, in cocultures with myoblastic C2C12 cells, VSELs form EB-like structures, VSEL-derived spheres (VSEL-DSs) that contain primitive stem cells able to differentiate into cells from all three germ layers. 10 On the one hand, this suggests that VSELs are a quiescent cell population and that some mechanisms must exist to prevent their unleashed proliferation and teratoma formation. On the other hand, the ability of VSELs to change their quiescent fate in cocultures with C2C12 cells shows that their quiescent status could be modulated. This supports the overall concept that VSELs may contribute to rejuvenation of organs and tissue repair. 15 However, the molecular mechanisms that modulate both pluripotency and quiescence of these cells remain unclear. Identification of these mechanisms is not only important to understand better the biological significance of the presence of VSELs in adult tissues but also crucial for the future use of these cells in regenerative medicine.
We have hypothesized that quiescence of VSELs could be modulated similarly as in PGCs, by status of DNA methylation on some developmentally important imprinted genes. 15 Genomic imprinting is an epigenetic process responsible for the paternal-specific, mono-allelic expression of the so-called imprinted genes. 16 There are B80 imprinted genes (expressed from maternal or paternal chromosomes only) for which proper mono-allelic expression regulates the totipotential status of the zygote and pluripotency of developmentally early stem cells. [17] [18] [19] In addition, most imprinted genes such as insulin-like growth factor 2 (Igf2), H19, Igf2 receptor (Igf2R) and p57 Kip2 (also known as Cdkn1c) have a direct role in embryo development. 16 The majority of imprinted genes exist as gene clusters enriched for CpG islands and their expression is coordinately regulated by DNA methylation status on CpG-rich cis elements known as differently methylated regions (DMRs). The DMRs are differentially methylated on CpG sites by DNA methyltransferase (Dnmts), depending on the parental allele origin. 20 In addition, depending on the developmental period of methylation, 'primary DMRs' are differentially methylated during gametogenesis, and 'secondary DMRs' acquire allele-specific methylation after fertilization. 21 So far, 15 primary DMRs have been identified in the mouse genome. Interestingly, most DMRs are methylated in the maternal allele and only three DMRs (Igf2-H19, Rasgrf1, Meg3 loci) are paternally methylated. 22 Although DMR methylation is of primary importance, histone modifications also contribute to monoallelic expression of these genes. 23, 24 In this study, we show that the proliferative quiescence of VSELs could be epigenetically controlled by DNA methylation on some developmentally important imprinted genes. Moreover, for the first time, we provide molecular evidence for an open/active chromatin structure in Oct4 promoter in VSELs, supporting that Oct4 could be truly expressed in stem cells isolated from adult tissues.
Materials and methods

Animals and preparation of BM cells for FACS
This study was performed in accordance with the guidelines of the Animal Care and Use Committee of the University of Louisville School of Medicine and with the Guide for the Care and Use of Laboratory Animals (Department of Health and Human Services, Publication No. NIH 86-23). Murine mononuclear cells (MNCs) were isolated from BM of pathogen-free, 4-to 6-week-old female and male C57BL/6 or C57BL/ 6-Tg(ACTB-EGFP)1Osb/J mice (Jackson Laboratory, Bar Harbor, ME, USA). Isolated by flushing bones, BM cell suspensions were lysed in BD lysing buffer (BD Biosciences, San Jose, CA, USA) for 15 min in room temperature (rt) and washed twice in phosphate-buffered saline (PBS).
Isolation of VSELs from BM by FACS
þ ) cells were isolated from 4-6-week-old mice BM cells by multiparameter, live cell sorting (FACSVantage SE; Becton Dickinson, Mountainview, CA, USA or MoFlo, Dako A/S, Fort Collins, CO, USA). 10 Briefly, BM-MNCs (10 Â 10 7 cells per ml) were resuspended in cell-sort medium containing 1 Â Hank's Balanced Salt Solution without phenol red (GIBCO, Grand Island, NY, USA), 2% heat-inactivated fetal calf serum (FCS; GIBCO), 10 mM HEPES buffer (GIBCO) and 30 U/ml of Gentamicin (GIBCO). The following monoclonal antibodies (mAbs) were employed for cell staining: biotin-conjugated rat anti-mouse Ly-6A/E (Sca-1) (clone E13-161.7); streptavidin-PECy5 conjugate; anti-CD45-APC-Cy7 (clone 30-F11); anti-CD45R/B220-PE (clone RA3-6B2); anti-Gr-1-PE (clone RB6-8C5); anti-TCRab PE (clone H57-597); anti-TCRgz PE (clone GL3); anti-CD11b PE (clone M1/70) and anti-Ter-119 PE (clone TER-119). All mAbs were added at saturating concentrations and the cells were incubated for 30 min on ice and washed twice before being resuspended for sorting in cell-sort medium at a concentration of 5 Â 10 6 cells per ml. Double-sorted populations of cells were used.
Formation of VSEL-DSs and cell culture
The VSEL-DSs were cultured as described earlier 10 and cells isolated from VSEL-DSs at days 5, 7 and 11 were used in our studies. Murine ESC-D3 cells were purchased from ATCC (Rockville, MD, USA) and grown in Dulbecco's modified Eagle's medium (DMEM; GIBCO) containing 4 mM L-glutamine, 1.5 g/l sodium bicarbonate, 4.5 g/l glucose, 0.1 mM b-mercaptoethanol (Sigma, St Louis, MO, USA), 15% heat-inactivate d fetal bovine serum (FBS; GIBCO), 100 IU/ml penicillin, 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA, USA) and 5 ng/ml of recombinant mouse LIF (Chemicon-Millipore, Billerica, MA, USA) without a feeder layer. EB formation was performed by the hanging drop method. The human hematopoietic cell line, THP-1, and murine BM STs were maintained in RPMI-1640 (GIBCO) and DMEM medium, respectively, supplemented with 10% FBS, 100 IU/ml penicillin, 100 mg/ml streptomycin and 2 mM L-glutamine.
Carrier chromatin-immunoprecipitation (Carrier-ChIP)
Carrier-ChIP analysis was performed as described earlier with some modifications. 25 Instead of Drosophila melanogaster SL2 cells, THP-1 cells were used as a source of carrier chromatin. The ChIP assay was performed using the Magna ChIP G kit (Upstate-Millipore, Billerica, MA, USA) according to the manufacturer's instructions. In brief, 5 Â 10 6 THP-1 cells were resuspended in culture media and mixed with 2 Â 10 4 freshly isolated VSELs, HSCs, BM-MNCs, ESC-D3s and EB-derived cells. The cell mixtures were subsequently fixed with 1% formaldehyde in culture media for 10 min at rt with rotation. Excess of formaldehyde was quenched by adding 10 Â glycine stock followed by incubation for 5 min at rt. The cross-linked chromatins of cell mixtures were subsequently sheared by sonication (Model 150 T, Fisher Scientific, Pittsburgh, PA, USA) at 40% amplitude (four times 15 s pulse on with incubation at ice for 1 min at intervals) in 200 ml of Nuclear Lysis Buffer. After centrifugation at 10 000 g at 4 1C for 10 min, sheared chromatin was immunoprecipitated using Protein G magnetic beads, conjugated with 3 mg of ChIP grade antibodies against H3Ac (Upstate-Millipore), H3K9me2 (Abcam, Cambridge, MA, USA) or rabbit immunoglobulin (Ig)G control antibodies (Sigma). The bound and unbound sheared cross-linked chromatins were subsequently eluted according to the manufacturer's instructions. PCRs were performed using Amplitaq Gold Taq (Applied Biosystems, Foster City, CA, USA), primers for murine sequencespecific Oct4, Nanog or b-actin promoter (Supplementary Table 1 ) at the first cycle of 8 min at 95 1C, second cycle of 2 min at 95 1C, 1 min at the annealing temperature (AT) and 1 min at 72 1C. Subsequently, the reaction was set as follows: indicated cycles of 30 s at 95 1C; 1 min at AT1C and 1 min at 72 1C, followed by 1 cycle of 10 min at 72 1C. The AT was 62 1C for Oct4, 60 1C for Nanog and 65 1C for b-actin. Finally, the PCR products were visualized by electrophoresis on 2% agarose gel. To quantify the enrichment of each histone modification, we applied RQ-PCR using qChIP primer sets (Supplementary Table  1 ). The copy number of bound or unbound PCR products was calculated by the absolute quantification method. The enrichment of each histone modification was calculated as the ratio of amplicon amounts from bound (B) to unbound (UB) fractions and fold differences are shown as mean±s.d. from at least four independent experiments. All the clones obtained by employing these ChIP primers were subsequently sequenced to rule out the possibility of amplification of Oct4 pseudogenes or nonspecific sequences (data not shown).
Bisulfite-sequencing and combined bisulfite-restriction analysis (COBRA)
The DNA methylation status of the promoters of pluripotent regulators (Oct4, Nanog) and DMRs of imprinted-genes were investigated using bisulfite DNA modification followed by sequencing as well as by COBRA assay. In brief, genomic DNA was prepared from double-sorted VSELs, HSCs, STs, ESC-D3 s and cells derived from VSEL-DSs (2 Â 10 4 ) using the DNeasy Blood and Tissue Kit (Qiagen Inc., Valencia, CA, USA). Next, 100 ng of gDNA were used in bisulfite modification, performed using the EpiTect Bisulfite Kit (Qiagen Inc.) according to the manufacturer's instructions. DMRs of imprinted-genes were amplified by nested PCR using bisulfite-treated gDNA and specific primers (Supplementary Table 1 ). Both first-and
The role of genomic imprinting in Oct4 þ VSELs DM Shin et al second-round PCRs were performed at two cycles of 2 min at 95 1C, 1 min at 55 1C, 1 min at 72 1C, and subsequently at 35 cycles of 30 s at 95 1C, 1 min at 55 1C, 1 min at 72 1C and one cycle of 10 min at 72 1C. After agarose gel electrophoresis, amplicons were eluted using QIAquick Gel Extraction Kits (Qiagen Inc.). Eluted amplicons were subsequently ligated into pCR2.1-TOPO vector and transformed into TOP10 bacteria using a TOPO TA Cloning Kit (Invitrogen). The plasmids were prepared using a QIAprep Spin Miniprep Kit (Qiagen Inc.) and sequenced with M13 forward and reverse primers. The methylation pattern in DMRs was analyzed using the CpGviewer software. 26 The COBRA assay was performed by cutting amplicons of DMRs with TaqI or BstUI restriction enzyme for 2 h and subsequently by agarose gel electrophoresis, as described earlier. 18 All experiments were conducted with three independent isolations of all the cell populations and two independent PCRs of each isolated cell.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA from various cells was isolated using the RNeasy Mini Kit (Qiagen Inc.) including the treatment of DNase I (Qiagen Inc.). The mRNA (10 ng Table  2 ). All primers were designed with Primer Express software (Applied Biosystems), as at least one primer included an exonintron boundary.
Real-time quantitative PCR (RQ-PCR)
Quantitative assessment of mRNA levels of target genes was performed by RQ-PCR using an ABI Prism 7500 Sequence Detection System (Applied Biosystems). The cDNA templates from each cell were amplified using SYBR Green PCR Master Mix (Applied Biosystems) and specific primers (Supplementary Table 2 ). All primers were designed with Primer Express software (Applied Biosystems), as at least one primer included an exon-intron boundary. In case of Oct4 expression analysis, the already published primer set was used, 9 and by sequencing the PCR products, we exclude the possibility of amplification of Oct4 pseudogenes or nonspecific sequences (data not shown). The threshold cycle (C t ), the cycle number at which the fluorescence of amplified gene reached a fixed threshold, was subsequently determined and the relative quantification of the expression level of target genes was performed with the 2 ÀDDCt method, using the mRNA level of b2-microglobulin as an endogenous control gene and that of ST as a calibrator.
Immunocytochemistry
Immunocytochemistry for Oct4, SSEA-1, p57 KIP2 (polyclonal, Abcam), Dnmt1 (C-17, polyclonal, Santa Cruz, Santa Cruz, CA, USA) and Dnmt3b (N-19, polyclonal, Santa Cruz) proteins was performed as described earlier. 10 
Statistical analysis
All the data in quantitative ChIP and gene expression analysis were analyzed using one factor ANOVA with Bonferroni's Multiple Comparison Test. We used the Instat1.14 program (GraphPad, La Jolla, CA, USA) and statistical significance was defined as Po0.05 or Po0.01.
Results
The open chromatin structure of Oct4 promoter in VSELs A few recent reports cast some doubt on whether Oct4 þ cells are truly present in adult tissues. 8, 9 These reports suggested that Oct4 expression in putative candidates of PSCs could merely be a result of the detection of Oct4 pseudogenes by RT-PCR or unspecific staining. Therefore, it becomes important to reappraise these data and to see if Oct4 is truly expressed in candidate PSCs isolated from adult tissues. Figure 1a) . First, we reconfirmed that highly purified VSELs, similar to ESC cell-line ESC-D3, express Oct4 both at the mRNA and protein levels (Figure 1b and c) . Next, as expression of Oct4 is repressed in differentiated cells by a mechanism involving promoter methylation, 27 we examined the DNA methylation status of the Oct4 promoter ( Figure 1d ) by using bisulfite sequencing in murine VSELs, HSCs, BM-derived stroma-cells (STs) and in cells isolated from ESC-D3-derived 1-day embryoid bodies (EBs) (Figure 1e ). We noticed that the Oct4 promoter in VSELs, similar to EBs, is hypomethylated (28% and 13.2%, respectively). In contrast, the Oct4 promoter was hypermethylated in adult HSCs (63.4%) and STs (60.4%), as expected.
To provide additional direct evidence that the Oct4 promoter in VSELs is in an active/open state, we performed the chromatinimmunoprecipitation (ChIP) assay to evaluate its association with acetylated-histone3 (H3Ac) and dimethylated-lysine-9 of histone3 (H3K9me2), the molecular features for open-and closed-type chromatin, respectively. 28 To overcome the problem of low number of VSELs, we performed the Carrier-ChIP assay using the human hematopoietic cell-line THP-1 as a carrier. As shown in Figure 1f , the Oct4 promoter chromatin association with H3Ac was detected in both VSELs and ESC-D3, but not in primary HSCs, BM MNCs and THP-1 cells, even in PCRs after using high cycle numbers (Supplementary Figure 1) . Furthermore, RQ-PCR analysis of the ChIP products revealed that the Oct4 promoter in VSELs was highly enriched for H3Ac, in a manner similar to ESC-D3 and EB (1-day) cells, and its association with H3K9me2 was relatively very low ( Figure 1g) . Interestingly, in contrast to BM-derived MNCs, the Oct4 promoter in HSCs showed a weak association with both H3Ac and H3K9me2. As VSELs also express Nanog, we evaluated the epigenetic status of the Nanog promoter in these cells as well. We found that the Nanog promoter was methylated (B50%), however, quantitative ChIP data confirmed that the H3Ac/H3K9me2 ratio supports the active status of the Nanog promoter in VSELs (Supplementary Figure 2) .
Thus, this part of our experiments strongly supported our previous data that VSELs truly express Oct4 and Nanog.
The unique genomic imprinting patterns result in a quiescent transcriptome of VSELs
As mentioned above, highly purified BM-derived VSELs do not proliferate in vitro if cultured alone. On the basis of the expression of PSC markers and primitive morphology, we
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hypothesized that the quiescence of VSELs could be controlled in a manner similar to epiblast-derived PGCs by erasure/ modification of methylation on some developmentally important imprinted-genes. 15 To test whether VSELs, similar to PGCs, undergo epigenetic reprogramming/modification of genomic imprinting, we first investigated the DNA methylation status on DMRs of paternally methylated imprinted genes (Igf2-H19, Rasgrf1 and Meg3) (Figure 2a) . The rationale was that paternally The role of genomic imprinting in Oct4 þ VSELs DM Shin et al imprinted genes are much less frequent 22 and, more importantly, that the proper mono-allelic imprint of the Igf2-H19 genes was crucial for obtaining viable parthenogenetic mice derived from a reconstructed oocyte containing two haploid sets of maternal genomes. 29 We noticed that VSELs showed significant hypomethylation (B10%) of the DMR for the Igf2-H19 locus (Figure 2b ). In contrast, this region was normally methylated (B50%) in HSCs and STs and even slightly hypermethylated in ESC-D3 (Figure 2b ). These bisulfite-sequencing results were subsequently confirmed by combined bisulfiterestriction analysis (COBRA) (Figure 2e ). Next, we investigated the methylation status of DMRs for Rasgrf1 and Meg3 and found that VSELs in contrast to other cells erase imprinting on the DMR for Rasgrf1 (Figure 2c) . However, the DMR for Meg3 is properly methylated (Figure 2d ). These results indicate that VSELs erase the genomic imprinting on DMRs for paternally imprinted Igf2-H19 and Rasgrf1 loci, in a manner similar to PGCs, 30 but not at the DMR for Meg3.
Next, we examined DMRs for selected maternally methylated (Kcnq1, Igf2R) loci that are mostly well studied for regulation of embryo growth (Figure 3a) . We found that DMRs for both maternally imprinted loci, Kcnq1 (Figure 3b ) and Igf2R (Figure 3c ), were hypermethylated in VSELs. At the same time, all these regions were normally methylated (B50%) in adult HSCs and STs. Highly proliferative ESC-D3 cells showed opposite methylation patterns in DMRs for Kcnq1 (Figure 3b ), Igf2-H19 (Figure 2b ) and Rasgrf1 (Figure 2c ) loci, compared with VSELs. These bisulfite-sequencing results were subsequently confirmed by COBRA assay (Figure 3d ). When we investigated other maternally methylated (Peg1, SNRPN) genes, we found that the DMR for Peg1 was hypermethylated ( Figure 3e) ; however, the DMR for SNRPN was slightly hypomethylated (Figure 3f The role of genomic imprinting in Oct4 þ VSELs DM Shin et al the maternally methylated DMRs. It is accepted that although paternally expressed imprinted genes (Igf2, Rasgrf1) enhance the embryo growth, maternally expressed ones (H19, p57 KIP2 , Igf2R) inhibit cell proliferation. 16 Therefore, the differences observed on VSELs show growth-repressive imprints in these cells.
To confirm our DMR methylation results, we performed RQ-PCR analysis of expression of imprinted genes that should presumably be affected by the observed changes in genomic imprinting. As expected, according to the chromatin insulator (CTCF) model, 31, 32 VSELs downregulate mRNA for Igf2 (Figure 4a ) and Rasgrf1 (Figure 4b ) while highly upregulating H19 simultaneously (Figure 4a ). However, H19 and Igf2 were highly expressed in ESC-D3 cells (Figure 4a) , and the ratio of H19/Igf2 mRNA for VSELs and ESC-D3 was B400 vs B1, respectively. This suggests that a proper balance in expression of both these genes may regulate the proliferation of PSCs as seen in (i) oocyte-derived parthenogenetic mice, 29 (ii) PGC-derived embryonic germ cells, 33 (iii) nuclear transfer clonotes, 17 and (iv) iPSCs. 5 Rasgrf1 is one of the Ras-specific guanine nucleotide exchange factors that activates the Ras protein and is highly upregulated in several human malignancies. 34 Therefore, selective downregulation of this gene in VSELs is also intriguing and requires further study.
In contrast to CTCF-regulated genes (Igf2-H19, Rasgrf1), a different mechanism regulates the expression of Igf2R and Kcnq1. 20 The DMRs for these loci are located in the promoters of the antisense transcripts (Air and Lit1, respectively) that coordinately repress the expression of clustered imprinted genes ( Figure 3a) . As expected for hypermethylation of DMRs for Igf2R and Kcnq1 (Figure 3) , VSELs downregulate the expression of Air The role of genomic imprinting in Oct4 þ VSELs DM Shin et al and Lit1 (Figure 4c and d) . As a result of this, VSELs highly express Ig2R (Figure 4c ) and, more importantly, highly upregulate p57 KIP2 , a known negative regulator of the cell cycle (Figure 4d and e) . In addition to p57 KIP2 , we also evaluated other cyclin-dependent kinases (Cdks) or inhibitors (CDKIs). We found high expression of p21
Cip1 , but no significant differences in the expression level of Cdks2, 4 and 6, which suggest that CDKIs could have more important roles in VSEL quiescence than Cdks (Supplementary Figure 3) .
Some of the DMRs of imprinted genes are located directly in their promoters (for example, Peg1). Although the Peg1 DMR was hypermethylated in VSELs, these cells highly express mRNA for this gene (Figure 4f ), in a similar manner to ESC-D3 cells. The high level of Peg1 expression in VSELs, similar to that observed in embryonic cells, 35 further supports their embryonic-like character.
On the basis of our data, all the epigenetic reprogramming of genomic imprinting in VSELs results in a quiescent transcriptome by the upregulation of growth-repressive genes (H19, p57 KIP2 , Igf2R) and downregulation of growth-promoting genes (Igf2, Rasgrf1). Therefore, these unique changes in the methylation patterns reveal a potentially novel mechanism involved in regulating the pluripotency of early developmental stem cells deposited in adult tissues.
VSELs highly express Dnmts
As the methylation status of imprinted genes and their expression is regulated by Dnmts (Dnmt1, Dnmt3b, Dnmt3a, Dnmt3L), we focused on the expression of these genes in VSELs. Dnmt1 is believed to be responsible for the maintenance of DNA methylation and Dnmt3a and 3b are accountable for de novo DNA methylation. 36 Furthermore, Dnmt3L, a gene that shares homology with the Dnmt3 family methyltransferases despite the lack of enzymatic activity, is also essential for DNA methylation of imprinted genes. 37 As reported, undifferentiated ESCs highly express Dnmts and Dnmt-deficient ESCs die during differentiation, indicating that Dnmts perform essential roles in maintaining pluripotency and differentiation of ESCs. 36 We noticed that VSELs highly express all Dnmts in a manner similar to ESCs and, in particular, are highly enriched for mRNA for Dnmt3L (Figure 5a ). The intranuclear expression of Dnmt1 and Dnmt3b in VSELs was additionally confirmed by immunostaining ( Figure 5b ). As the expression of de novo Dnmts and Dnmt3 L is low in differentiated somatic cells, the high expression of these Dnmts in VSELs suggests their high epigenetic plasticity, similar to that observed in ESCs.
The reprogramming of genomic imprinting during VSELDSs formation
Finally, although purified VSELs remain quiescent if cultured alone in vitro, they grow VSEL-DSs in cocultures with C2C12 cells as reported earlier. 10 This suggests that their quiescent status can be modulated by epigenetic reprogramming in VSELs after cell-to-cell contact with the C2C12 supportive cell line. To address this better, we analyzed the DNA methylation of the Oct4 promoter and selected imprinted-genes in cells isolated from VSEL-DSs at days 5, 7 and 11 ( Figure 6a ). We observed both gradual hypermethylation of the Oct4 promoter and occurrence of the somatic methylation pattern on DMRs for Igf2-H19, Rasgrf1, Igf2R, Kcnq1 and Peg1 (Figure 6b and Supplementary Figure 4) . The results summarized in Figure 6b suggest that growth-repressive genomic imprinting in VSELs is gradually restored in stem cells that form VSEL-DS, which suggests that VSELs may show dynamic epigenetic plasticity The role of genomic imprinting in Oct4 þ VSELs DM Shin et al potential similar to ESCs. However, the restoration of genomic imprints in cells isolated from VSEL-DSs is paralleled by the hypermethylation of the Oct4 promoter (Figure 6b ), which suggests that cells present in these spheres gradually lose their pluripotency. Therefore, these results show that the DNA methylation of the Oct4 promoter and DMRs in certain imprinted genes both orchestrate the pluripotent and quiescent status of VSELs (Figure 6c ).
Discussion
This study provides, for the first time, molecular evidence at the chromatin level that the Oct4 gene is actively transcribed in VSELs isolated from adult BM. In addition, our methylation studies of the Oct4 promoter and crucial imprinted genes show novel mechanisms that may prevent the 'unleashed' proliferation of developmentally early stem cells deposited in adult tissues. VSELs show some similarities in the methylation pattern to PGCs, which suggests their close relationship to epiblast/ germline cells (Figure 6c) .
Some recent reports cast some doubts whether Oct4 could be truly expressed in cells isolated from adult tissues and prompt us to reappraise the expression of Oct4 in VSELs. To rule out an argument that Oct4 expression could be the result of misinterpretation of RT-PCR and immunostaining results, we used (i) Oct4-specific primers that do not amplify pseudogenes, (ii) removed during RNA isolation contaminating genomic DNA by deoxyribonuclease I (DNase I) treatment, (iii) confirmed the PCR products by DNA sequencing and iv) showed the intranuclear localization of Oct4 protein. More importantly, we performed epigenetic analysis (DNA methylation and histone modifications) of the Oct4 promoter (Figure 1 ). Our data provide strong molecular evidence at the chromatin level that the Oct4 gene is truly transcribed in VSELs isolated from adult BM. Similarly, by performing a similar approach, we also provided evidence for an open status of the Nanog promoter.
Furthermore, in this study, we confirmed our hypothesis that VSELs show some unique genomic imprinting patterns that regulate their quiescent status. The role of the status of genomic imprinting in the regulation of pluripotentiality was described for another epiblast-derived stem cell population, PGCs. These germline-committed stem cells gradually reprogram/erase their genomic imprinting during migration to genital ridges (8.5-12.5 d.p.c.). 30 Erasure of genomic imprint in PGCs shows that these pluripotent cells (i) are quiescent, ii) do not complete blastocyst development and iii) PGCs-derived nuclei, in contrast to any other somatic cell nuclei, are ineffective as DNA donors for nuclear transfer. 17 We noticed that in VSELs (Figure 2 and 3 ), paternally methylated DMRs (Igf2-H19 and Rasgrf1), in a manner similar to PGCs, are hypomethylated, in contrast to maternally methylated ones (Kcnq1, Igf2R and Peg1) that remain hypermethylated in VSELs.
The methylation status of DMRs is regulated by Dnmts. Although PGCs express Dnmt1, both Dnmt3a and Dnmt3 L are not expressed in these cells. 30, 38 Furthermore, VSELs in contrast to PGCs highly express all types of Dnmts ( Figure 5 ), particularly Dnmt3L that is important for establishing maternal methylated imprints. 37 Thus, the high expression of DNA methylation machinery in VSELs could explain the hypermethylation status of maternally imprinted DMRs. However, despite the potentially high capacity of DNA methylation in these cells, we noticed that paternally methylated DMRs for Igf2-H19, and Rasgrf1 loci were erased. To explain this striking discrepancy, we found that VSELs highly express the chromatin insulator CTCF gene that prevents the methylation of paternally imprinted DMRs (data not shown). Therefore, the high CTCF expression could protect the methylation of paternally methylated DMRs in these cells. This notion could be further supported by our additional observation showing that VSELs show a slight hypomethylation in DMR for SNRPN, which is also regulated by CTCF. 31 On this basis, we postulate that the balance between Dnmts and CTCF expression influences a final outcome of DMR methylation patterns in VSELs. The role of genomic imprinting in Oct4 þ VSELs DM Shin et al It is well known that imprinted genes have crucial roles in fetal growth, development, pluripotency of stem cell and tumorigenesis. As a result of the unique reprogramming of genomic imprinting, VSELs show the upregulation of growthrepressive imprinted genes (H19, p57 KIP2 , Igf2R) and downregulation of growth-promoting genes (Igf2, Rasgrf1) ( Figure 4) . As Igf2 has been described as an important autocrine growth factor that promotes the expansion of several cell types 39 and, in contrast, H19 regulatory mRNA was found to inhibit cell proliferation, 40 the changes in expression of both these genes are probably responsible for a quiescent status of VSELs. Importantly, the significance of a proper mono-allelic imprint of the Igf2-H19 gene was shown to be crucial in the generation of viable parthenogenetic mice using two haploid sets of maternal genomes. 29 In addition, as the non-signaling receptor Igf2R functions as a decoy receptor for Igf2, which prevents its availability for Igf1R, 41 the upregulation of Igf2R in VSELs may additionally protect VSELs from autocrine/paracrine stimulation by Igf2. Another important gene that is downregulated by changes in DMR methylation is Rasgrf1, a protein involved in Igf1R-signaling transduction. 42 Thus, our preliminary data suggest that VSELs show some changes in the expression of genes that are related to Igf-signaling machinery. The elucidation of a potential role of these factors in the quiescence/ activation of VSELs; however, requires further complex studies.
Furthermore, we noticed that VSELs highly express the p57 KIP2 transcript as a result of hypermethylation of DMR in the Kcnq1 locus. As the specific upregulation of p57 KIP2 is responsible for the transforming growth factor b-induced quiescence of primitive human HSCs 43 and murine BM side population cells, 44 these results indicate that p57 KIP2 could also have a significant role in maintaining quiescence of VSELs. More importantly, our data also showed that all these changes in genomic imprinting that affect the pluripotent and quiescent status of VSELs revert when these cells expand/differentiate into VSEL-DSs.
In conclusion, in this study, we provide molecular evidence that some rare Oct4
þ VSELs are present in adult tissues. We hypothesize that these cells could serve as a backup for tissuecommitted monopotent SCs and that their proliferative potential is tightly regulated by both (i) Oct4 expression and the ii) methylation status of some imprinted genes that are directly involved in the regulation of cell proliferation (for example, Igf2, H19, Igf2R, p57 KIP2 , Rasgrf1). Therefore, the potential modulation of mechanisms that control genomic imprinting in VSELs would be crucial for developing more powerful strategies to unleash the regenerative potential of these cells to use them efficiently in the clinic. The role of genomic imprinting in Oct4 þ VSELs DM Shin et al
